skip to main content

Main Site Navigation

Top of main content
Redefining DigestiveCare Around You.
WATCH VIDEO
AUDIO DESCRIPTIONS

Research and Clinical Trials

At Carle, we understand the importance of research and the role research plays in providing quality care to our patients. Research initiatives offer new information about how to combat disease, show new ways of thinking about treatment and possible cures. Carle physicians also partner with scientists at the University of Illinois to study evolving fields in the science of microbiomes, inflammatory bowel disease, C diff, constipation, and other gut related illnesses.

Carle Digestive Health physicians are involved in many ongoing clinical research studies and clinical trials for Inflammatory Bowel Disease (IBD), including Crohn's Disease and Ulcerative Colitis.

Our skilled physicians are invested in this research to further understand these chronic, sometimes debilitating gastrointestinal (GI) diseases and conditions. To learn more about digestive health research, visit our list of clinical trials or call (844) 37-RESEARCH (844-377-3732) or email us.

Effects of Alcohol After Bariatric Surgery (RBA)

The investigators wish to study the effects of three forms of bariatric surgery: gastric bypass, sleeve gastrectomy, and lap banding. The surgery is not part of the clinical trial. If insurance does not cover the procedure, then the patient is responsible for payment of the surgical process. The investigators are doing pre- and post-surgery testing to provide a better understanding of the effect of bariatric surgery-induced weight loss on 1) alcohol absorption, distribution and elimination from the body; 2) the effects of alcohol on blood sugar; and 3) the effects of alcohol on mood.

Fecal Microbiota Transplant National Registry (FMT)

This registry will prospectively enroll 4,000 patients who undergo FMT at 75 sites throughout North America. Information on FMT methodology employed (e.g., screening of donor and recipient, preparation, FMT delivery) will be collected from each site. The indication for FMT as well as baseline information on recipient will also be collected. Following FMT, patients will be followed at regular intervals up to 10 years post FMT. This will include follow-up information from the patient's healthcare provider at 1 month, 6 months, 1 year, and 2 years after FMT as well as direct communication with patients at least annually up to 10 years after FMT. Follow-up information collected will be designed to assess potential short-term and long-term safety and effectiveness.

AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH

The AURORA study will be conducted to confirm the efficacy and safety of cenicriviroc (CVC) for the treatment of liver fibrosis in adult subjects with NASH.

SEE MORE CLINICAL TRIALS

Meet Our Team

With doctors practicing in 80 specialties at locations throughout the region, it’s easy to find the right healthcare team at Carle. Our mission is to serve people through high quality care, medical research and education.

MEET OUR TEAM

Giving

Charitable gifts are used for numerous projects and programs that enhance the healthcare experience for digestive health patients and their loved ones. With your support, we’ll expand the scope of services offered and further Carle’s dedication to the diagnosis and treatment of digestive issues.

DONATE NOW GIVING AT CARLE

Related Events

Feb. 5, 2020
6 p.m.
Feb. 19, 2020
6 p.m.
March 4, 2020
6 p.m.

Awards and Accreditations

Recognized among the nation’s top hospitals, Carle provides excellent healthcare while continuously improving to meet the needs of our patients.

    • Commission on Cancer - Certified Rectal Cancer Facility
    • National Association for Gastrointestinal Endoscopy